Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety
对HER2阳性原发性乳腺癌日本女性患者进行每3周一次的新辅助化疗(曲妥珠单抗、多西他赛和卡铂):疗效和安全性
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-017-1136-8
Sugitani, Ikuko; Ueda, Shigeto; Sakurai, Takashi; Shigekawa, Takashi; Hirokawa, Eiko; Shimada, Hiroko; Takeuchi, Hideki; Matsuura, Kazuo; Misumi, Misono; Fujiuchi, Nobuko; Takahashi, Takao; Hasebe, Takahiro; Osaki, Akihiko; Saeki, Toshiaki